MacroCure Ltd.

www.macrocure.com

High-Tech Company

Acquired by Leap Therapeutics

TAGS

Biologicals, Chronic Wounds Treatment, Medical Devices

General Data

Sector	Life Sciences
Sub-Sector	Biotechnology

TECHNOLOGY

CureXcell® is comprised of a mixture of white blood cells including monocytes/macrophages, neutrophils and lymphocytes obtained from young (18-40 yrs old) healthy donor blood which is activated by a safe and simple yet patented process. Cur...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

Second Round

Mar. 27, 2011

R&D

$13m

$103m

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Sep 11, 2016